Biochemical studies have shown that both the alpha and beta chain of human haemoglobin (Hb) is glycosylated by glucose and glycolytic intermediates in a non-enzymatic process in vitro and in vivo [1, 2, 3] .
Since glucose bound in ketoamine-linkage to the N-terminal valine of the haemoglobin beta chain, haemoglobin Ale (HbAlc), is believed to be stable within the erythrocyte, the relative concentration of HbAlc may reflect the integrated blood glucose concentration over a period of time. HbAlc thus has potential for assessment of long-term glycaemic control in diabetics.
A number of studies have shown a statistically significant correlation between diabetic "control" based on conventional parameters and the relative concentration of HbAI~ or total fast chromatographing haemoglobins (HbA0 [4, 5, 6] . So far the magnitude of correlation coefficients reported, especially in insulin-treated diabetics, does not support unambiguous assessment of glycaemic control in the individual diabetic patient by HbAlc.
Precise assessment of glycaemic control in insulintreated diabetics is a major difficulty in studying the value of HbAlc, but, as previously reported [7, 8] , codetermination of unstable, rapidly formed glycosylated haemoglobin may add to the uncertainty in evaluating the clinical value of HbAlc.
The present study deals with further investigation of the rapid glycosylation of haemoglobin.
Methods
For routine measurement of HbA~c, 0.15 ml venous or capillary blood was diluted in 3 volumes of heparin-saline (50 IU/ml -0.15 mol/1) and stored for a maximum of 48 h at 4 ~ before preparation of haemolysates. After 3 washings in 0.15 mol/1 saline, lysis of packed red blood cells (RBC) was achieved by adding one volume of distilled water and 0.4 volumes of tetrachloromethane. After centrifugation at5000 g, clear haemolysates were diluted to 1 mmol/1 Hb (16 g/l) with eluting buffer (46 mmol/1 sodium phosphate and 10 mmol/l potassium cyanide, pH 6.68) and chromatographed within 2 h. For in vitro studies and for quality control, haemolysates were prepared similarly but in larger volumes.
Chromatography was performed on 20 simultaneously run 0.9 x 7 cm glass columns packed with the ion exchange resin Bio-Rex 70, minus 400 mesh (BioRad Laboratories, USA). A constant elution speed of 0.5 ml/min was obtained with a 20 channel Multiflex Roller Pump (O. Dich Instruments, Denmark). Between determinations the resin was reequilibrated with eluting buffer for at least 6 h. Diluted haemolysate, 0,5 ml (8-10 mg Hb), was applied to each column through the pump and fast chromatographing haemoglobins collected in 18 fractions, each of 2.5 ml, directly into disposable cuvettes for a 2074 Calculating Absorptiometer (LKB, Sweden). Thereafter haemoglobin A (HbA) was eluted in one fraction by running phosphate buffer pH 6.42 as described by Trivelli [9] for 30 rain followed by eluting buffer for 60 rain, giving a total of 45 ml for elution of HbA. Elution of the HbAlc peak in fractions 8-10 was achieved without thermostating the columns, by adjusting the ionic strength of eluting buffer according to the ambient temperature. The ionic strength was decreased by approximately 1%/degree rise in ambient temperature above 18 ~ pH, measured at 37 ~ was kept constant at 6.68 +_ 0.01.
For each sample absorbance of the fractions, 18 for glycosylated haemoglobins and 1 for HbA, was read at 417 mn and the relative concentration of the haemoglobin fractions (HbA~+b, HbAlc and HbA) was calculated from the absorbance values, defining the curve minimum (cut off point) between HbAl,+b and HbAl~ peaks by parabolic regression analysis and correcting for baseline deviation after the HbA~c peak.
Purified HbAlc for recovery studies was prepared according to McDonald [10] .
Studies of short-term changes in HbA~o concentration were performed in vitro by incubation of 0.15 ml blood with 1.0ml 0.15 mol/1 saline with additions as specified. Changes during incubation were calculated as the differences between aliquots of the sample incubated with a specified glucose concentration and aliqnots incubated in 0.15 tool/1 saline for the same time and at the same temperature. In these experiments, all samples from any one subject were chromatographed in the same run. Blood glucose concentration was determined by a modification of the Trinder glucose oxidase method [11] .
The thiobarbiturate reaction (TBA) for 2-keto-hexose derivatives was performed according to Gabbay [12] , but haemolysates were dialyzed overnight at 4~ against 0.15 tool/1 saline before determination of TBA-reactive material was performed. 5-hydroxy-methylfurfural (5-HMF) (Merck) was used as standard. The results were corrected for individual blanks before calculation of ~tmol 5-HMF liberated/mmol Hb.
The least square regression and Wilcoxon's rank sum tests were used for statistical analysis.
Patients
The studies were performed on I) 6 insulin-treated male diabetics aged 16M7 years (mean 36 years) and with a duration of diabetes of 7-29 years (mean 15 years). Glycaemic control on SC insulin before connection to the artificial pancreas was achieved by 0.71 U kg -1 day -1 (range 0.48-1.16 U kg -~ day-l). Mean blood glucose concentration over 3 days before connection to the artificial pancreas was 11.5 retool/1 (range 8.9-18.0). All had a body-weight within 103-109% of the ideal body-weight [13] , and none of the patients showed a Cpeptide response to a 1 mg IV glucagon stimulation test. All six patients were treated with an artificial pancreas for 48 h before start of the experiment.
2) 22 diabetics from the out-patient clinic of Steno Memorial Hospital. Based on 24-hour urinary glucose excretion they were divided into two groups: DI, excreting low amounts of glucose (3-20 g ) and group Dn excreting high amounts (70-228 g). Eight patients from group D~ were insulin-dependent, 1 patient controlled by diet alone and 1 by diet and a sulfonylurea. The patients' ages ranged from 23 to 70 years (mean 44 years) with diabetes for 3-21 years (mean 10 years); The insulin-treated patients received an average of 0.48 U kg-day -I and had body-weights within 85-115% (mean 103%) of ideal. The 2 non-insulin-dependent diabetics had body-weights of 121 and 142% of the ideal, respectively. In group DII the patients' ages ranged from 19 to 67 years (mean 45 years) with diabetes for 4-40 years (mean 16 years). One patient was controlled by diet plus sulfonylurea and the other 11 by 0.23-2.22 U insulin kg-~day -1 (mean 0.67). All had body-weights within 85-115% of ideal. One patient in group DI had elevated serum creatinine (143 ~mol/1). All other patients had normal values (50-120 ~mol/1). Blood was collected as described above after informed consent was obtained.
Blood samples from non-diabetic subjects were obtained from volunteers of this hospital (n= 40) and from old people from a geriatric unit (n = 18). Some of the latter were taking drugs for cardiovascular atherosclerotic disease including mild to moderate hypertension.
The artificial beta-cell (Biostator, Miles) was employed to control blood glucose as previously described [14] .
Results

Methodology
Hb elution curves for a normal (5% HbAxc ) and a diabetic sample (12% HbAlc) are shown in Figure 1 .
Linearity of HbAa c measurements in the expected range was tested by analysis of mixtures of haemolysates prepared from one normal subject (5% HbAI~) and from one newly diagnosed diabetic (13% HbAlc ) (Table 1) . Deviation from linearity was less than 2% with a coefficient of correlation of 1.00 (Table 1) . Recovery of purified HbAI~ chromatographed on 5 routine columns average 98.6% (SEM 1.4%). The HbAI~ concentration remained stable for at least 3 days in whole blood stored at 4 ~ and for 1-2 days in blood diluted with 0.15mol/1 saline and stored at 4 ~ After an initial decrease of 9% during the first month of storage at -40 ~ the HbAI~ values in haemolysates were unchanged (Table2). Accordingly haemolysates stored at -40 ~ for more than 1 month were used for assessment of analytical variation. Except in whole blood stored at 4 ~ the HbAia+b fraction continued to increase during storage. Changes during storage could not be accounted for by oxidation as no changes in glycosylated fractions were found when samples of haemolysate were partially oxidized to haemoglobin by potassium ferric cyanide (haemoglobin-fraction up to 0.28) before chromatography.
Intraassay variation for fresh samples chromatographed on three different days and interassay variation in HbA~ concentration for a normal and a diabetic sample are given in Table 3 .
The normal range for HbAlc concentration was 4.4-6.4% (mean + 2 SD, n = 58, mean age 54 years, range 20-92 years). For the same normal subjects a statistically significant correlation was found between age and HbAl~+b concentration (HbAla+b = 0.0093 x years + 1.4, r = 0.64,2 P < 0.001). For the sum of HbA,a+b and HbAlc fractions, gbA1, the correlation with age was also significant (HbAi = 0.016 x years + 6.4, r = 0.43, 2 P < 0.001). The HbAlc concentration was not correlated to age (r --0.06). Using samples from normal and diabetic subjects less than 70 years of age (HbAI~ concentration between 4.5 and 16%), a significant correlation was found between concentration of HbAla+b and HbAI~ (HbAl,+b = 0.14 x HbAI~ + 1.0, r = 0.85, n = 79, 2P < 0.001).
In Vitro Experiments
Rapid increases in chromatographically determined HbAI~ in red blood cells (RBC) from normal subjects were demonstrated after incubation at 37 ~ in glucose-saline (Table 4) . At each glucose concentration, the maximum increase in HbA~r concentration was a 2P > 0.05, b 2P < 0.001 for difference from preincubation value reached within 4-8 h, the maxima being proportional to glucose concentration. No significant changes were observed during an additional 12-20 h. In blood samples from 6 normal subjects incubated at 37 ~ with 100 mmol/1 glucose-saline, the increase in HbAIr concentration was linear only during the first 60 rain (Table 5 ). Mean increase = 0.034% HbAlc x h -1 x mmol/1 glucose -1 (SEM 0.003). In 2 h the HbAla+b concentration (not shown) increased by 0.32% (SEM 0.05). After 2 h incubation, the medium was changed to saline without glucose and changes in the HbAI~ concentration followed for another 2 h (Table 5 ). For the individual subjects, the resulting decrease in the HbAlc concentration was linear with time during the 2 h investigated. The mean change was -0.017% HbAlc x h -1 x mmol/1 glucose -1 (SEM 0.001). During the 2 h at low glucose, a decrease in HbAla+b concentration of 0.18% (SEM 0.06) was found. Incubation of RBC from normal and diabetic subjects at 3 different glucose concentrations for 2 h showed no difference in response (Table 6) .
Rapidly formed HbAIr was not completely dissociated by a 2 h incubation of RBC in glucose-free medium (Table 5 ). In other experiments it was found that the disappearance of rapidly formed HbAlc continued for 4-6 h at 37 ~ in saline. Thereafter the HbAlc concentration was stable for at least 24 h. Using a 6 h incubation in saline at 37 ~ to dissociate unstable HbAlc, we investigated whether stable HbAI~ was produced in RBC from normal subjects by incubation in 100 mmol/1 glucose-saline for 2 and 24 h at 37 ~ After 24 h a statistically significant amount of non-dissociable HbAlc (mean 1.3%) was produced ( Table 7) .
From Table 2 it is seen that HbA~r in diabetic RBC diluted in 0.15 mol/1 saline is stable for at least 24 h. Blood samples from 10 diabetics (mean % HbAlc 9.8, range 7.5-13.8)and from 10 normal subjects (mean % HbAlc 5.2, range 4.45.7) were diluted in 0.15 mol/1 saline and incubated both at 4 ~ and 37 ~ for 24 h. Mean difference in the HbAlc concentration, % HbAlc at 4 ~ -% HbAlc at 37 ~ for diabetic samples was 0.85% HbAlc (range 0.3-1.6) and for normal samples 0.15% HbAlc (range 0.03-0.3). By non-parametric testing, the decrease in HbAlc in diabetic samples was significantly different from that of normal samples.
In another 18 fleshly drawn diabetic samples it was tested whether decreases in HbAlc concentration, like decreases in samples after rapid in vitro induced increases in the HbAlc concentration, were maximal after a 6 h incubation period in 0.15 mol/1 saline at 37 ~ The mean value for HbAlc concentration after a 6 h incubation in saline was 9.34% (SEM 0.57) and still 9.34% (SEM 0.56) after a further 18-hour incubation.
To test whether a decrease in HbAI~ concentration during incubation of RBC in 0.15 mol/1 saline at 37 ~ was dependent on glycaemic control during the previous 24h, blood samples from diabetic outpatients excreting low amounts of glucose in a 24 h urine collection, Group D I (n = 10, mean excretion 10 g, range 3-20, mean HbAI~ concentration 9.2%) and high amounts of glucose, Group DII (n = 12, mean excretion 105 g, range 70-228, mean HbAlc concentration 10.7%) were incubated in 0.15 mol/1 saline at 4 ~ and 37 ~ for 16 h. Samples from nondiabetics (n = 10, mean HbAI~ concentration 5.2%) were treated identically. The mean differences between the HbAI~ concentration in samples incubated at 4 ~ and 37 ~ were not significant for Groups D I and Dn (mean decrease 0.61 and 0.68%, ranges 0.2-1.2 and 0.1-1.4%), but in both cases higher than the decrease in Group N (0.21% HbAlc) (2 P < 0.01 in both cases). In the combined DI and DII groups a significant correlation between the actual concentration of glucose in blood at time of sampling and the decrease in HbA~c concentration during incubation at 37 ~ was calculated (~ = 0.54, 2 P < 0.01).
In order to study the chemical nature of rapidly produced HbAI~, blood samples from 3 normal and 4 diabetic subjects were incubated in 0.15 mol/1 saline or saline plus 50 or 100 mmol/1 glucose for 2 h at 37 ~ Haemolysates from each incubate were dialyzed overnight at 4 ~ against 0.15 mol/1 saline and the next day subjected to chromatographical determination of glycosylated haemoglobins and to estimation of 5-HMF liberated during boiling with oxalic acid according to Gabbay [13] .
From Table 8 it will be noted that the mean increase in chromatographically determined HbAlc concentration of 25 and 50% respectively did not result in any increase in ~mol 5-HMF/mmol Hb. For samples incubated in 0.15 mol/1 saline a significant correlation between HbAlc concentration and ~tmol 5-HMF/mmol Hb was calculated (5-HMF --2.31 • HbA~ + 1.35, r = 0.99, 2P < 0.001).
Clinical Studies
The results from a diabetic patient studied after feedback control in an artificial pancreas are shown in Figure 2 . Feed-back control with the Biostator for up TableS. Changes in % HbAlc, and 5-hydroxymethylfurfuraldehyde (5-HMF) liberated by the thiobarbiturate reaction, after incubation of normal and diabetic red blood cells in 0, 50 and 100 mmolJl glucose-saline at 37 ~ to 48 h before the start of the experiment resulted in near normal glucose concentrations in all 4 diabetics investigated (mean blood glucose concentration during 24h before experiment 6.3mmol/1, range 5.1-7.8). Rapid changes in blood glucose concentration accomplished by withdrawal of insulin and IV infusion of glucose produced in increase in HbAlc concentration in all 4 patients (mean increase 1.1%, range 0.7-1.9%) within 6--11 h after increase in blood glucose concentration of 8-19 mmol/1 above the mean over the previous 24 h. Another 2 diabetics had subcutaneous insulin withdrawn 24 h before connection to the Biostator, resulting in blood glucose concentrations of 28 and 18 mmol/1 when' feed-back control was started. In these 2 patients, a decrease of 1.8 and 0.8% HbAIr respectively was measured within 6 h of normalisation of blood glucose.
Discussion
Several pitfalls in the chromatographic determination of glycosylated hhemoglobins have been described, including instability of glycosylated haemoglobins, column temperature, presence of lipaemia or abnormal haemoglobins, and variation in erythrocyte lifespan. Our results suggest that the rapid fo?mation of an unstable glycosylated haemoglobin fraction should be added to the list.
The chromatography method used in this study is essentially that described by Trivelli [9] , using however an ion exchange resin of low particle size, a slightly lower pH in the eluting buffer, complete reequilibration of resin between runs, and adjustment of the ionic strength of the eluting buffer according to ambient temperature. In this way a reproducible separation of HbAla+b and HbAI~ is obtained over 90 min and using 45 ml of eluant.
The normal range published for HbAlc concentration is clearly dependent upon the method used, but the range found in the present study is within those found using chromatographic methods [15, 16] . As [17] we found a correlation between HbAz and age, but in contrast to [18] not for HbAIr in normals aged 20-92 years. This may indicate that HbAa~ concentration estimated by our method is unable to detect the decrease in glucose tolerance with age, or that the lifetime of RBC decreases with age. The correlation between HbAxa+b concentration and age has not to our knowledge been reported before. The significance of this finding is obscure. Like other investigators [6, 16] we found a correlation between concentration of UbAla+b and HbAac in a combined group of normal and diabetic subjects. As reported by Dunn [19] the HbAla+b fraction was unstable during storage. The initial decrease in HbAI~ during storage of diabetic haemolysates may be the same process but at a slower rate than that occurring during incubation of RBC at 37~ in low glucose medium (Table 4, 6 ).
The chemical nature of stable HbAI~, a ketoamine-linkage between glucose and the N-terminal valine of the beta haemoglobin chain, has convincingly been clarified [20, 21] , but the Schiff base being proposed as the initial step in the synthesis of HbAtr from HbA and glucose has so far not been identified. Hence its stability and chromatographic behaviour in the systems used for determination of glycosylated haemoglobins is unknown. Rapid in vitro synthesis of HbAIr in intact erythrocytes or in haemolysates has previously been described [15] . Spicer [22] , determining HbAlc by isoelectric focusing, reported parallel increases in HbAI~ in normal and diabetic RBC after incubation with glucose at 37 ~ for 6-20 h. Flfickiger [23] found the increase to be the same after 8 and 18 h incubation. Bunn [24] reported that subsequent dialysis at 37 ~ in glucosefree medium reduced the amount of HbAIr formed during incubation of carboxyhaemoglobin with 25 mmol/1 glucose, and he concluded that part of glucose in rapidly formed HbAlc is bound in an unstable linkage.
Rapid in vivo changes in HbA1 concentration have been noted less frequently. Karamanos [25] and Bolli [26] found significant changes in diabetics within 3 days. Leslie [27] reported a mean decrease of 2.5% HbA1 in 1 week. The present study is to our knowledge the first report of significant changes taking place within hours.
Furthermore, our in vitro experiments show that HbAI~ may be increased significantly within a few hours when RBC are incubated in a glucose-containing medium. We also found that the peak increase in HbAlc concentration is reached within 4~5 h at 37 ~ (Table 4) and that the increase is reversible by incubation in a glucose-free medium for 4~ h at 37 ~ The rate of increase and maximal increase were correlated to glucose concentrations in the incubation medium. The HbAlc increase was not different in RBC from normal and diabetic subjects. Elevation of glucose concentration for 24 h, but not 2 h, led to a significant increase in non-dissociable HbAI~.
Previously we reported [8] that rapid increase in HbA~c concentration resulted in a slight change in its chromatographic behaviour. Since only glucose bound in ketoamine linkage is determined in the thiobarbiturate reaction [12] , we conclude from the results in Table 8 that no significant amounts of ketoamine-HbA~c are formed by short-term increases in HbAI~, and we have found (unpublished observations) that the HbAI~ band on isoelectric focusing may be separated into 2 when rapidly produced HbAIr is present. It is therefore possible that the substance measured after rapidly induced increases in the UbAlc concentration might be the intermediate Schiff base precursor of stable ketoamine-HbA~.
The rapid changes in HbAlo measured in diabetics after treatment with an artificial pancreas show directly formation and dissociation of the unstable HbAI~ compound in vivo. The findings in out-patient diabetics of a blood glucose-dependent decrease in HbAt~ concentration due to incubation of RBC in a low-glucose medium at 37 ~ indirectly suggests that rapid changes in HbAlc concentration do occur in "normal" diabetic life. In diabetic patients we measured as much as 1.9% unstable HbAlc representing up to 15-30% of the usual concentration of HbAlc seen in our diabetic patients (6--12% HbAlc). This clearly represents a problem in the use of HbAlc concentration as an indicator of long-term glycaemic control.
Our results also indicate however that this pitfall may be abolished by incubation of RBC in low-glucose medium for at least 4h at 37~ before chromatographic determination.
